We are live on ! Find out more
KT

Kanaly Trust Portfolio holdings

AUM $471M
1-Year Est. Return 15.12%
This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+15.12%
3 Year Est. Return
+11.56%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$549M
AUM Growth
+$34.7M
Cap. Flow
+$15K
Cap. Flow %
0%
Top 10 Hldgs %
64.65%
Holding
761
New
65
Increased
161
Reduced
206
Closed
40

Top Buys

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$7.79M
2
VOD icon
Vodafone
VOD
+$981K
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$946K
4
MCD icon
McDonald's
MCD
+$638K
5
CELG
Celgene Corp
CELG
+$539K

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$1.85M
2
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$1.83M
3
XOM icon
ExxonMobil
XOM
+$1.26M
4
J icon
Jacobs Solutions
J
+$1.15M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$928K

Sector Composition

Rank Sector Weight
1 Energy 46.4%
2 Healthcare 3.93%
3 Consumer Staples 3.22%
4 Financials 2.54%
5 Technology 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKM icon
376
SK Telecom
SKM
$13.7B
$26K ﹤0.01%
612
+194
+46% +$7.56K
RTN
377
DELISTED
Raytheon Company
RTN
$26K ﹤0.01%
287
– –
FTI icon
378
TechnipFMC
FTI
$30.6B
$25K ﹤0.01%
559
– –
ISRG icon
379
Intuitive Surgical
ISRG
$121B
$25K ﹤0.01%
549
– –
IWM icon
380
iShares Russell 2000 ETF
IWM
$80.9B
$25K ﹤0.01%
210
– –
MSI icon
381
Motorola Solutions
MSI
$69.4B
$25K ﹤0.01%
383
+26
+7% +$1.71K
CVRR
382
DELISTED
CVR Refining, LP
CVRR
$25K ﹤0.01%
1,000
– –
HR
383
DELISTED
Healthcare Realty Trust Incorporated
HR
$25K ﹤0.01%
1,000
– –
ECL icon
384
Ecolab
ECL
$75.6B
$24K ﹤0.01%
213
– –
FLR icon
385
Fluor
FLR
$7.29B
$24K ﹤0.01%
316
-10
-3% -$762
KYN icon
386
Kayne Anderson Energy Infrastructure Fund
KYN
$2.52B
$24K ﹤0.01%
603
– –
SAP icon
387
SAP
SAP
$187B
$24K ﹤0.01%
309
+67
+28% +$5.21K
XLP icon
388
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$24K ﹤0.01%
546
– –
SRCL
389
DELISTED
Stericycle Inc
SRCL
$24K ﹤0.01%
202
– –
APH icon
390
Amphenol
APH
$188B
$23K ﹤0.01%
1,920
– –
DVA icon
391
DaVita
DVA
$15.1B
$22K ﹤0.01%
305
– –
KN icon
392
Knowles
KN
$3.22B
$22K ﹤0.01%
+718
New +$21.7K
NRP icon
393
Natural Resource Partners
NRP
$1.3B
$22K ﹤0.01%
135
– –
OVTI
394
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$22K ﹤0.01%
+1,000
New +$20.4K
BUD icon
395
AB InBev
BUD
$158B
$21K ﹤0.01%
185
+130
+236% +$14.3K
CRM icon
396
Salesforce
CRM
$134B
$21K ﹤0.01%
369
+12
+3% +$648
TEP
397
DELISTED
Tallgrass Energy Partners, LP
TEP
$21K ﹤0.01%
547
– –
SD
398
DELISTED
SANDRIDGE ENERGY, INC.
SD
$21K ﹤0.01%
3,000
– –
ADBE icon
399
Adobe
ADBE
$89.5B
$20K ﹤0.01%
277
-58
-17% -$3.74K
BPT
400
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$20K ﹤0.01%
200
– –
14 15
16
17 18

Similar funds

TM
Thrax Management New York $547M AUM 26.41% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
PC
Perry Capital New York $334M AUM 8.27% 1-Year Est. Return
BWM
Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return
HPBT
High Point Bank & Trust High Point, North Carolina $315M AUM 12.21% 1-Year Est. Return
JIAI
JCF III AIV I New York $299M AUM 7.51% 1-Year Est. Return
BGE
BLS Global Equities Klampenborg, Denmark $297M AUM
BREA
Barings Real Estate Advisers Hartford, Connecticut $294M AUM 6.38% 1-Year Est. Return

Kanaly Trust's Q2 2014 Portfolio in Review

As of Q2 2014, Kanaly Trust held 761 positions worth $549M, up 6.7% from $514M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Kanaly Trust's Q2 2014 filing shows 65 new, 161 increased, 206 reduced and 40 closed positions. Its largest new stake was Vodafone: 27,720 shares worth $926K. The largest sale was AstraZeneca, an estimated $1.85M.

By sector, the portfolio is most concentrated in Energy at 46% of assets, up from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Kanaly Trust's largest Q2 2014 buy was Vodafone: 27,720 shares worth $926K.
  • Kanaly Trust added most to iShares Russell 1000 Value ETF in Q2 2014, an estimated $7.79M increase.
  • Kanaly Trust's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $1.85M.
  • Kanaly Trust fully exited Weatherford International plc in Q2 2014, selling an estimated $614K.
  • Kanaly Trust's ten largest holdings make up 65% of its $549M portfolio in Q2 2014.
  • Kanaly Trust opened 65 new positions and closed 40 in Q2 2014.
  • Kanaly Trust's portfolio value rose 6.7% quarter-over-quarter to $549M.

Based on Kanaly Trust's 13F filing for Q2 2014, filed 28 Jul 2014.